Home » Authors » Catherine Hollingsworth

Articles by Catherine Hollingsworth

Bio-Path Becomes Public in Merger with Ogden Golf

March 5, 2008

By Catherine Hollingsworth

Bio-Path Becomes Public in Merger with Ogden Golf

March 5, 2008

By Catherine Hollingsworth

Pfizer Acquires Serenex for Undisclosed Amount

March 4, 2008

By Catherine Hollingsworth

Pfizer Acquires Serenex for Undisclosed Amount

March 4, 2008

By Catherine Hollingsworth

Biogen Idec Offers $1B in Senior Notes for Debt

March 3, 2008

By Catherine Hollingsworth

Biogen Idec Offers $1B in Senior Notes for Debt

March 3, 2008

By Catherine Hollingsworth

Regeneron IL-1 Blocker Arcalyst Not Seen as Rival to Kineret

Feb. 29, 2008

By Catherine Hollingsworth

Regeneron IL-1 Blocker Arcalyst Not Seen as Rival to Kineret

Feb. 29, 2008

By Catherine Hollingsworth

RegeneRx Secures $5M for Wound Healing Trials

Feb. 28, 2008

By Catherine Hollingsworth

Receptor Logic Finds Partner to Develop T-Cell Mimics

Feb. 28, 2008

By Catherine Hollingsworth